BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30657986)

  • 1. Shared Molecular Targets Confer Resistance over Short and Long Evolutionary Timescales.
    Li J; Vázquez-García I; Persson K; González A; Yue JX; Barré B; Hall MN; Long A; Warringer J; Mustonen V; Liti G
    Mol Biol Evol; 2019 Apr; 36(4):691-708. PubMed ID: 30657986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into TOR function and rapamycin response: chemical genomic profiling by using a high-density cell array method.
    Xie MW; Jin F; Hwang H; Hwang S; Anand V; Duncan MC; Huang J
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7215-20. PubMed ID: 15883373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Heterogeneity Influences the Fate of New Adaptive Mutations.
    Vázquez-García I; Salinas F; Li J; Fischer A; Barré B; Hallin J; Bergström A; Alonso-Perez E; Warringer J; Mustonen V; Liti G
    Cell Rep; 2017 Oct; 21(3):732-744. PubMed ID: 29045840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast.
    Helliwell SB; Wagner P; Kunz J; Deuter-Reinhard M; Henriquez R; Hall MN
    Mol Biol Cell; 1994 Jan; 5(1):105-18. PubMed ID: 8186460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.
    Loewith R; Jacinto E; Wullschleger S; Lorberg A; Crespo JL; Bonenfant D; Oppliger W; Jenoe P; Hall MN
    Mol Cell; 2002 Sep; 10(3):457-68. PubMed ID: 12408816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.
    Alarcon CM; Cardenas ME; Heitman J
    Genes Dev; 1996 Feb; 10(3):279-88. PubMed ID: 8595879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Talking TOR: a conversation with Joe Heitman and Rao Movva.
    Williams CL
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467327
    [No Abstract]   [Full Text] [Related]  

  • 8. Redesigning TOR Kinase to Explore the Structural Basis for TORC1 and TORC2 Assembly.
    Hill A; Niles B; Cuyegkeng A; Powers T
    Biomolecules; 2018 Jun; 8(2):. PubMed ID: 29865216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Screen Reveals
    Wong LH; Flibotte S; Sinha S; Chiang J; Giaever G; Nislow C
    G3 (Bethesda); 2017 Apr; 7(4):1251-1257. PubMed ID: 28235825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.
    Zheng XF; Florentino D; Chen J; Crabtree GR; Schreiber SL
    Cell; 1995 Jul; 82(1):121-30. PubMed ID: 7606777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common mechanism involving the TORC1 pathway can lead to amphotericin B-persistence in biofilm and planktonic Saccharomyces cerevisiae populations.
    Bojsen R; Regenberg B; Gresham D; Folkesson A
    Sci Rep; 2016 Feb; 6():21874. PubMed ID: 26903175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression.
    Kunz J; Henriquez R; Schneider U; Deuter-Reinhard M; Movva NR; Hall MN
    Cell; 1993 May; 73(3):585-96. PubMed ID: 8387896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary engineering and molecular characterization of a caffeine-resistant Saccharomyces cerevisiae strain.
    Sürmeli Y; Holyavkin C; Topaloğlu A; Arslan M; Kısakesen Hİ; Çakar ZP
    World J Microbiol Biotechnol; 2019 Nov; 35(12):183. PubMed ID: 31728740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
    Alarcon CM; Heitman J; Cardenas ME
    Mol Biol Cell; 1999 Aug; 10(8):2531-46. PubMed ID: 10436010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsp90 and environmental stress transform the adaptive value of natural genetic variation.
    Jarosz DF; Lindquist S
    Science; 2010 Dec; 330(6012):1820-4. PubMed ID: 21205668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.
    Sabatini DM; Erdjument-Bromage H; Lui M; Tempst P; Snyder SH
    Cell; 1994 Jul; 78(1):35-43. PubMed ID: 7518356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saccharomyces cerevisiae Tel2 plays roles in TORC signaling and telomere maintenance that can be mutationally separated.
    Rozario D; Siede W
    Biochem Biophys Res Commun; 2012 Jan; 417(4):1182-7. PubMed ID: 22227188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional variomics tool for discovering drug-resistance genes and drug targets.
    Huang Z; Chen K; Zhang J; Li Y; Wang H; Cui D; Tang J; Liu Y; Shi X; Li W; Liu D; Chen R; Sucgang RS; Pan X
    Cell Rep; 2013 Feb; 3(2):577-85. PubMed ID: 23416056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of low mutation rates in experimental mutator populations of Saccharomyces cerevisiae.
    McDonald MJ; Hsieh YY; Yu YH; Chang SL; Leu JY
    Curr Biol; 2012 Jul; 22(13):1235-40. PubMed ID: 22727704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Game of TOR - The Target of Rapamycin Rules Four Kingdoms.
    Manning BD
    N Engl J Med; 2017 Sep; 377(13):1297-9. PubMed ID: 28874074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.